92 research outputs found
Direct Higgs production and jet veto at the Tevatron and the LHC in NNLO QCD
We consider Higgs boson production through gluon--gluon fusion in hadron
collisions, when a veto is applied on the transverse momenta of the
accompanying hard jets. We compute the QCD radiative corrections to this
process at NLO and NNLO. The NLO calculation is complete. The NNLO calculation
uses the recently evaluated NNLO soft and virtual QCD contributions to the
inclusive cross section. We find that the jet veto reduces the impact of the
NLO and NNLO contributions, the reduction being more sizeable at the LHC than
at the Tevatron.Comment: 22 pages, 12 postscript figure
Towards improving early diagnosis of congenital Chagas disease in an endemic setting.
: Congenital Trypanosoma cruzi transmission is now estimated to account for 22% of new infections, representing a significant public health problem across Latin America and internationally. Treatment during infancy is highly efficacious and well tolerated, but current assays for early detection fail to detect >50% of infected neonates and 9 month follow-up is low. : Women presenting for delivery in two urban hospitals in Santa Cruz department, Bolivia were screened by rapid test. Specimens from infants of infected women were tested by microscopy (micromethod), quantitative PCR (qPCR) and IgM trypomastigote excreted-secreted antigen (TESA)-blots at birth and 1 month, and by IgG serology at 6 and 9 months. : Among 487 infants of 476 seropositive women, congenital T. cruzi infection was detected in 38 infants of 35 mothers (7.8%). In cord blood, qPCR, TESA-blot and micromethod sensitivities/specificities were 68.6%/99.1%, 58.3%/99.1% and 16.7%/100%, respectively. When birth and 1 month results were combined, cumulative sensitivities reached 84.2%, 73.7% and 34.2%, respectively. Low birth weight and/or respiratory distress were reported in 11 (29%) infected infants. Infants with clinical signs had higher parasite loads and were significantly more likely to be detected by micromethod. : The proportion of T. cruzi infected infants with clinical signs has fallen from the 1990s, but symptomatic congenital Chagas disease still represents a significant, albeit increasingly challenging to detect, public health problem. Molecular methods could facilitate earlier diagnosis and circumvent loss to follow-up but remain logistically and economically prohibitive for routine screening in resource-limited settings.<br/
Toward Improving Early Diagnosis of Congenital Chagas Disease in an Endemic Setting.
BACKGROUND: Congenital Trypanosoma cruzi transmission is now estimated to account for 22% of new infections, representing a significant public health problem across Latin America and internationally. Treatment during infancy is highly efficacious and well tolerated, but current assays for early detection fail to detect >50% of infected neonates, and 9-month follow-up is low. METHODS: Women who presented for delivery at 2 urban hospitals in Santa Cruz Department, Bolivia, were screened by rapid test. Specimens from infants of infected women were tested by microscopy (micromethod), quantitative PCR (qPCR), and immunoglobulin (Ig)M trypomastigote excreted-secreted antigen (TESA)-blots at birth and 1 month and by IgG serology at 6 and 9 months. RESULTS: Among 487 infants of 476 seropositive women, congenital T. cruzi infection was detected in 38 infants of 35 mothers (7.8%). In cord blood, qPCR, TESA-blot, and micromethod sensitivities/specificities were 68.6%/99.1%, 58.3%/99.1%, and 16.7%/100%, respectively. When birth and 1-month results were combined, cumulative sensitivities reached 84.2%, 73.7%, and 34.2%, respectively. Low birthweight and/or respiratory distress were reported in 11 (29%) infected infants. Infants with clinical signs had higher parasite loads and were significantly more likely to be detected by micromethod. CONCLUSIONS: The proportion of T. cruzi-infected infants with clinical signs has fallen since the 1990s, but symptomatic congenital Chagas disease still represents a significant, albeit challenging to detect, public health problem. Molecular methods could facilitate earlier diagnosis and circumvent loss to follow-up but remain logistically and economically prohibitive for routine screening in resource-limited settings
Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy
Scientific Opinion on the hazard assessment of endocrine disruptors: Scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment
Upon request of the European Commission, the Scientific Committee (SC) of the European Food Safety Authority reviewed existing information related to the testing and assessment of endocrine active substances (EASs) and endocrine disruptors (EDs). This work was conducted by a working group of experts in endocrinology, risk assessment and toxicology, together with observers from other EU agencies, namely EMA, ECHA and EEA. To distinguish between EDs and other groups of substances with different modes of action, it was concluded that an ED is defined by three criteria: the presence of i) an adverse effect in an intact organism or a (sub)population; ii) an endocrine activity; and iii) a plausible causal relationship between the two. As scientific criteria for adversity have not been generally defined, specific criteria for endocrine disrupting effects could not be identified. Hence, expert judgement is required to assess on a case-by-case basis the (eco)toxicological relevance of changes at the molecular to individual and/or (sub)population level following exposure to an EAS. The SC concluded that a reasonably complete suite of standardised assays for testing the effects of EASs is (or will soon be) available for the oestrogenic, androgenic, thyroid and steroidogenic modalities in mammals and fish, with fewer tests for birds and amphibians. Shortcomings in current tests and for other endocrine modalities and species were reviewed. Critical effect, severity, (ir)reversibility and potency aspects are part of the hazard characterisation of EDs. To inform on risk and level of concern for the purpose of risk management decisions, risk assessment (taking into account hazard and exposure data/predictions) makes best use of available information. Levels of concern are not determined exclusively by risk assessment but also by protection goals set by the risk management
Biosphere Atmosphere Transfer. Part C: Integrative Modelling of Fluxes
roject phase. A highly qualified graduate student was finally found to work on this project: Christopher E. Sidle. He joined our research group in late October 1998. Principal results Within the region studied (Fig. 1) the total nitrogen input from the atmosphere to ecosystems is estimated to range between 22 and 51 kg of nitrogen per hectar per year. The results indicate that the critical loads of ecosystems sensitive to nitrogen inputs are exceeded by several kg of nitrogen per year. 13-42 kg of total annual deposition are deposited in gaseous form, 7-8 kg originate from precipitation (wet deposition), and roughly 2 kg are additional deposits of aerosol particles. Between 54% and 80% of total nitrogen deposition is reduced (NH x ) which is lost to the atmosphere from agricultural sources and losses from stables and manure storages. The greatest regional variation was found for dry deposition. In rural areas the deposition of reduced nitrogen dominates over oxidized forms (Fig. 1
The NLO multileg working group: Summary report
This report summarizes the activities of the NLM working group of the
Workshop "Physics at TeV Colliders", Les Houches, France, 11-29 June, 2007.
Comment: 119 pages, latex, many figures, summary report of the NLO multileg
working group of the Les Houches 2007 workshop "Physics at TeV Colliders",
Les Houches, France, 11-29 June, 2007; some references added or correcte
- …